Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Merck buys antibody design specialists

May 10, 2006 Research and Development

Merck is to buy a pioneering biotech company, which discovers new monoclonal antibodies and then re-engineers them to make them …
News

AstraZeneca abandons diabetes drug over safety concerns

May 5, 2006 Research and Development AstraZeneca, PPAR agonist

 AstraZeneca is to abandon its late-stage diabetes drug Galida after new results raised doubts about its safety.Galida is a PPAR …
News

Project management: from apprentice to master

May 3, 2006 Research and Development, Sales and Marketing

When the three 'Apprentices' enter Mr. Sugars boardroom to explain why they made such a hash of their latest project, …
Feature

Positive results halt trial of new Herceptin rival

May 3, 2006 Research and Development

Better than expected results for a new drug for advanced breast cancer have led to trials being halted, in order …
News

Biotech buy helps Pfizer expand neuroscience research

April 26, 2006 Research and Development, Sales and Marketing Pfizer

Pfizer is to buy Californian Rinat Neuroscience, a biotech company which specialises in developing therapeutic proteins to treat central nervous …
News

Companies share secrets to reduce unforeseen phase I problems

April 26, 2006 Research and Development

Eight of the industry's leading companies have begun work on a unique new project to help overcome one of the …
News

UK pharma industry unites to take the Code to customers

April 26, 2006 Research and Development

Companies from across the UK pharma industry have come together in an unprecedented campaign to promote awareness of its code …
News

Pfizer vows to fight ‘perverse and short-sighted decision’ on Exubera

April 24, 2006 Research and Development

Exubera, the world's first inhaled insulin, has failed to gain NICE approval after manufacturer Pfizer couldnt convince the Institute of …
News

GSK unveils first of new virtual pipeline drug discovery alliances

April 24, 2006 Research and Development

Pharmacopeia, a small New Jersey pharmaceutical company will be the first to enter into a new kind of drug development …
News

Wyeth to collaborate with Scottish universities on biomarkers

April 11, 2006 Research and Development

 Wyeth is to invest $86 million in a new collaboration with Scotland's leading medical researchers in a cutting edge area …
News

Fears for UK clinical trials as antibody inquiry proceeds

April 10, 2006 Research and Development

The MHRA is to put together an expert group to examine the need for new safety measures in the wake …
News

Lyrica to challenge antidepressants with new anxiety disorder approval

April 7, 2006 Research and Development

Pfizer's Lyrica is to go head to head with top-selling antidepressant drugs as it enters the market to treat generalised …
News

Novartis launch innovative leukaemia awareness campaign

March 30, 2006 Research and Development

Novartis has launched an innovative new campaign to raise awareness of leukaemia treatment among the UK's general practitioners; a move …
News

Novartis to develop Servier’s antidepressant for US

March 30, 2006 Research and Development

Novartis has signed a deal to develop and market Servier's new antidepressant and agomelatine for the US market.The drug has …
News

Novartis targets China with hepatitis drug

March 30, 2006 Research and Development

Novartis says trials of its new hepatitis drug in Chinese patients show it to be superior to standard treatment, in …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026